Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: A systematic review and meta-analysis

Journal of Neurosurgery

Volumn 122, Issue 5, 2015, Pages 1096-1112

  Konstantelias, Athanasios A ^a   Vardakas, Konstantinos Z ^a   Polyzos, Konstantinos A ^a   Tansarli, Giannoula S ^a   Falagas, Matthew E ^a,b  

^a IASO   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic impregnated catheters; Cerebrospinal shunt; External ventricular drainage; Hydrocephalus; Hydrogel catheters; Infection; Silver coated shunt; Ventriculoperitoneal shunt

Indexed keywords

ANTIINFECTIVE AGENT; DRUG CARRIER;

ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CEREBROSPINAL FLUID SHUNTING; DEVICES; DRAINAGE; EQUIPMENT DESIGN; HUMAN; HYDROCEPHALUS; INDWELLING CATHETER; META ANALYSIS;

ANTI-INFECTIVE AGENTS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CEREBROSPINAL FLUID SHUNTS; DRAINAGE; DRUG CARRIERS; EQUIPMENT DESIGN; HUMANS; HYDROCEPHALUS;

EID: 84936754369     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2014.12.JNS14908     Document Type: Article

References (56)

1. Abla AA, Zabramski JM, Jahnke HK, Fusco D, Nakaji P: Comparison of two antibiotic-impregnated ventricular catheters: a prospective sequential series trial. Neurosurgery 68:437-442, 2011
2. Albanese A, De Bonis P, Sabatino G, Capone G, Marchese E, Vignati A, et al: Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection. Acta Neurochir (Wien) 151:1259-1263, 2009
3. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML: Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56-61, 2005
4. Choksey MS, Malik IA: Zero tolerance to shunt infections: can it be achieved? J Neurol Neurosurg Psychiatry 75:87-91, 2004
5. Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M: Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr 1:444-450, 2008
6. Eymann R, Steudel WI, Kiefer M: Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children-a retrospective analysis. Klin Padiatr 221:69-73, 2009
7. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I: Rifampicin-impregnated central venous catheters: a metaanalysis of randomized controlled trials. J Antimicrob Chemother 59:359-369, 2007
8. Falagas ME, Siempos II: Prevention of ventilator-associated pneumonia: possible role of antimicrobials administered via the respiratory tract. Eur Respir J 31:1138-1139, 2008
9. Falagas ME, Siempos II, Bliziotis IA, Michalopoulos A: Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit Care 10:R123, 2006
10. Falagas ME, Vardakas KZ, Samonis G: Decreasing the incidence and impact of infections in neutropenic patients: evidence from meta-analyses of randomized controlled trials. Curr Med Res Opin 24:215-235, 2008
11. Farber SH, Parker SL, Adogwa O, McGirt MJ, Rigamonti D: Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: a single institution's experience. Neurosurgery 69:625-629, 2011
12. Fichtner J, Güresir E, Seifert V, Raabe A: Efficacy of silverbearing external ventricular drainage catheters: a retrospective analysis. J Neurosurg 112:840-846, 2010
13. Govender ST, Nathoo N, van Dellen JR: Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831-839, 2003
14. Gutiérrez-González R, Boto GR, Fernández-Pérez C, del Prado N: Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures. BMC Neurol 10:93, 2010
15. Gutiérrez-González R, Boto GR, Pérez-Zamarrón A: Cerebrospinal fluid diversion devices and infection. A comprehensive review. Eur J Clin Microbiol Infect Dis 31:889-897, 2012
16. Harrop JS, Sharan AD, Ratliff J, Prasad S, Jabbour P, Evans JJ, et al: Impact of a standardized protocol and antibioticimpregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery 67:187-191, 2010
17. Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL: The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 24:557-562, 2008
18. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12, 1996
19. James G, Hartley JC, Morgan RD, Ternier J: Effect of introduction of antibiotic-impregnated shunt catheters on cerebrospinal fluid shunt infection in children: a large single-center retrospective study. J Neurosurg Pediatr 13:101-106, 2014
20. Kan P, Kestle J: Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 23:773-777, 2007
21. Kandasamy J, Dwan K, Hartley JC, Jenkinson MD, Hayhurst C, Gatscher S, et al: Antibiotic-impregnated ventriculoperitoneal shunts-a multi-centre British paediatric neurosurgery group (BPNG) study using historical controls. Childs Nerv Syst 27:575-581, 2011
22. Kaufmann AM, Lye T, Redekop G, Brevner A, Hamilton M, Kozey M, et al: Infection rates in standard vs. hydrogel coated ventricular catheters. Can J Neurol Sci 31:506-510, 2004
23. Keong NC, Bulters DO, Richards HK, Farrington M, Sparrow OC, Pickard JD, et al: The SILVER (Silver Impregnated Line Versus EVD Randomized trial): a double-blind, prospective, randomized, controlled trial of an intervention to reduce the rate of external ventricular drain infection. Neurosurgery 71:394-404, 2012
24. Kestle JR, Riva-Cambrin J, Wellons JC III, Kulkarni AV, Whitehead WE, Walker ML, et al: A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative. J Neurosurg Pediatr 8:22-29, 2011
25. Klimo P Jr, Thompson CJ, Ragel BT, Boop FA: Antibioticimpregnated shunt systems versus standard shunt systems: a meta-and cost-savings analysis. J Neurosurg Pediatr 8:600-612, 2011
26. Lackner P, Beer R, Broessner G, Helbok R, Galiano K, Pleifer C, et al: Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 8:360-365, 2008
27. Lajcak M, Heidecke V, Haude KH, Rainov NG: Infection rates of external ventricular drains are reduced by the use of silver-impregnated catheters. Acta Neurochir (Wien) 155:875-881, 2013
28. Lane JD, Mugamba J, Ssenyonga P, Warf BC: Effectiveness of the Bactiseal Universal Shunt for reducing shunt infection in a sub-Saharan African context: a retrospective cohort study in 160 Ugandan children. J Neurosurg Pediatr 13:140-144, 2014
29. Lemcke J, Depner F, Meier U: The impact of silver nanoparticle-coated and antibiotic-impregnated external ventricular drainage catheters on the risk of infections: a clinical comparison of 95 patients. Acta Neurochir Suppl 114:347-350, 2012
30. Mikhaylov Y, Wilson TJ, Rajajee V, Thompson BG, Maher CO, Sullivan SE, et al: Efficacy of antibiotic-impregnated external ventricular drains in reducing ventriculostomy-associated infections. J Clin Neurosci 21:765-768, 2014
31. Muttaiyah S, Ritchie S, John S, Mee E, Roberts S: Efficacy of antibiotic-impregnated external ventricular drain catheters. J Clin Neurosci 17:296-298, 2010
32. Park YS, Park IS, Park KB, Lee CH, Hwang SH, Han JW: Laparotomy versus laparoscopic placement of distal catheter in ventriculoperitoneal shunt procedure. J Korean Neurosurg Soc 48:325-329, 2010
33. Parker SL, Anderson WN, Lilienfeld S, Megerian JT, Mc-Girt MJ: Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shunts. J Neurosurg Pediatr 8:259-265, 2011
34. Parker SL, Attenello FJ, Sciubba DM, Garces-Ambrossi GL, Ahn E, Weingart J, et al: Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst 25:77-85, 2009
35. Pattavilakom A, Xenos C, Bradfield O, Danks RA: Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci 14:526-531, 2007
36. Pople I, Poon W, Assaker R, Mathieu D, Iantosca M, Wang E, et al: Comparison of infection rate with the use of antibioticimpregnated vs standard extraventricular drainage devices: a prospective, randomized controlled trial. Neurosurgery 71:6-13, 2012
37. Ratilal B, Costa J, Sampaio C: Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. J Neurosurg Pediatr 1:48-56, 2008
38. Rehman AU, Rehman TU, Bashir HH, Gupta V: A simple method to reduce infection of ventriculoperitoneal shunts. J Neurosurg Pediatr 5:569-572, 2010
39. Richards HK, Seeley HM, Pickard JD: Efficacy of antibioticimpregnated shunt catheters in reducing shunt infection: data from the United Kingdom Shunt Registry. J Neurosurg Pediatr 4:389-393, 2009
40. Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE: Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 7:38, 2007
41. Rivero-Garvía M, Márquez-Rivas J, Jiménez-Mejías ME, Neth O, Rueda-Torres AB: Reduction in external ventricular drain infection rate. Impact of a minimal handling protocol and antibiotic-impregnated catheters. Acta Neurochir (Wien) 153:647-651, 2011
42. Rozzelle CJ, Leonardo J, Li V: Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2:111-117, 2008
43. Steinbok P, Milner R, Agrawal D, Farace E, Leung GK, Ng I, et al: A multicenter multinational registry for assessing ventriculoperitoneal shunt infections for hydrocephalus. Neurosurgery 67:1303-1310, 2010
44. Tamburrini G, Massimi L, Caldarelli M, Di Rocco C: Antibiotic impregnated external ventricular drainage and third ventriculostomy in the management of hydrocephalus associated with posterior cranial fossa tumours. Acta Neurochir (Wien) 150:1049-1056, 2008
45. Theophilus SC, Adnan JS: A randomised control trial on the use of topical methicillin in reducing post-operative ventriculoperitoneal shunt infection. Malays J Med Sci 18:30-37, 2011
46. Thomas R, Lee S, Patole S, Rao S: Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis. Br J Neurosurg 26:175-184, 2012
47. Vardakas KZ, Michalopoulos A, Falagas ME: Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol 131:22-28, 2005
48. Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME: Antifungal prophylaxis with azoles in highrisk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 34:1216-1224, 2006
49. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP: Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014-1021, 1984
50. Wang X, Dong Y, Qi XQ, Li YM, Huang CG, Hou LJ: Clinical review: Efficacy of antimicrobial-impregnated catheters in external ventricular drainage-a systematic review and meta-analysis. Crit Care 17:234, 2013
51. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (http://www.medicine.mcgill.ca/rtamblyn/Readings/The%20 Newcastle%20-%20Scale%20for%20assessing%20the%20 quality%20of%20nonrandomised%20studies%20in%20metaanalyses. pdf) [Accessed December 21, 2014]
52. Winkler KM, Woernle CM, Seule M, Held U, Bernays RL, Keller E: Antibiotic-impregnated versus silver-bearing external ventricular drainage catheters: preliminary results in a randomized controlled trial. Neurocrit Care 18:161-165, 2013
53. Woernle CM, Burkhardt JK, Bellut D, Krayenbuehl N, Bertalanffy H: Do iatrogenic factors bias the placement of external ventricular catheters?-a single institute experience and review of the literature. Neurol Med Chir (Tokyo) 51:180-186, 2011
54. Wong GK, Ip M, Poon WS, Mak CW, Ng RY: Antibioticsimpregnated ventricular catheter versus systemic antibiotics for prevention of nosocomial CSF and non-CSF infections: a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry 81:1064-1067, 2010
55. Wright K, Young P, Brickman C, Sam T, Badjatia N, Pereira M, et al: Rates and determinants of ventriculostomy-related infections during a hospital transition to use of antibioticcoated external ventricular drains. Neurosurg Focus 34(5):E12, 2013
56. Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, et al: Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 98:725-730, 2003